The U.S. Food and Drug Administration approved a human papillomavirus (HPV) vaccine for females aged 9–26 and males aged 9–21. It protects against the HPV types that most often cause cervical, vaginal, vulvar, and anal cancers. The HPV vaccine does not substitute for routine cervical cancer screening (Pap tests), according to recommended screening guidelines. Currently, screening tests for other types of HPV-associated cancers are not recommended.
For information on who should get the HPV vaccination, see HPV Vaccines.
Hepatitis B is a liver disease caused by the Hepatitis B virus (HBV). It ranges in severity from a mild illness, lasting a few weeks (acute), to a serious long-term (chronic) illness that can lead to liver disease or liver cancer. The hepatitis B vaccine is available for all age groups to prevent HBV infection.
For more information about cancer and vaccines, visit the National Cancer Institute's Cancer Vaccines.
- Centers for Disease Control and Prevention
Division of Cancer Prevention and Control
4770 Buford Hwy NE
Atlanta, GA 30341
TTY: (888) 232-6348
- Contact CDC-INFO